{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:30Z","timestamp":1786119630763,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.1097\/qai.0b013e318215ab0a","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T22:55:12Z","timestamp":1299279312000},"page":"109-117","source":"Crossref","is-referenced-by-count":6,"title":["Combined Antiretroviral Therapy and Immune Pressure Lead to In Vivo HIV-1 Recombination With Ancestral Viral Genomes"],"prefix":"10.1097","volume":"57","author":[{"given":"Maria Jos\u00e9","family":"Buz\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Wrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M","family":"Codo\u00f1er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bonjoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Coakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1371\/journal.pmed.0010036","article-title":"Limited durability of viral control following treated acute HIV infection.","volume":"1","author":"Kaufmann","year":"2004","journal-title":"PLoS Med"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.qai.0000197078.41150.0d","article-title":"Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children.","volume":"41","author":"Abadi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1310\/hct0906-387","article-title":"Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.","volume":"9","author":"Bonjoch","year":"2008","journal-title":"HIV Clin Trials"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/496892","article-title":"Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.","volume":"192","author":"Deeks","year":"2005","journal-title":"J Infect Dis"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"F79","DOI":"10.1097\/00002030-199907300-00002","article-title":"Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.","volume":"13","author":"Garcia","year":"1999","journal-title":"AIDS"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199905280-00001","article-title":"Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.","volume":"13","author":"Harrigan","year":"1999","journal-title":"AIDS"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002030-200003100-00013","article-title":"Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.","volume":"14","author":"Ruiz","year":"2000","journal-title":"AIDS"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jmv.2023","article-title":"Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations.","volume":"65","author":"Devereux","year":"2001","journal-title":"J Med Virol"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1128\/JVI.76.14.7000-7009.2002","article-title":"Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.","volume":"76","author":"Kijak","year":"2002","journal-title":"J Virol"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2006.07.037","article-title":"Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo.","volume":"384","author":"Briones","year":"2006","journal-title":"Gene"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/vir.0.19365-0","article-title":"Co-existence of recent and ancestral nucleotide sequences in viral quasispecies of human immunodeficiency virus type 1 patients.","volume":"85","author":"Bello","year":"2004","journal-title":"J Gen Virol"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/aid.2006.22.1260","article-title":"Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease.","volume":"22","author":"Kitchen","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1097\/00002030-199912240-00007","article-title":"Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.","volume":"13","author":"Verhofstede","year":"1999","journal-title":"AIDS"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1128\/JVI.72.5.3520-3523.1998","article-title":"Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.","volume":"72","author":"Yerly","year":"1998","journal-title":"J Virol"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection.","volume":"100","author":"Richman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1.","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood-2004-01-0251","article-title":"Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.","volume":"104","author":"Trkola","year":"2004","journal-title":"Blood"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput.","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/molbev\/msn083","article-title":"jModelTest: phylogenetic model averaging.","volume":"25","author":"Posada","year":"2008","journal-title":"Mol Biol Evol"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.","volume":"52","author":"Guindon","year":"2003","journal-title":"Syst Biol"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.0050050","article-title":"Episodic sexual transmission of HIV revealed by molecular phylodynamics.","volume":"5","author":"Lewis","year":"2008","journal-title":"PLoS Med"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/bioinformatics\/16.6.562","article-title":"RDP: detection of recombination amongst aligned sequences.","volume":"16","author":"Martin","year":"2000","journal-title":"Bioinformatics"},{"key":"R23-4-20210131","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/bioinformatics\/bth490","article-title":"RDP2: recombination detection and analysis from sequence alignments.","volume":"21","author":"Martin","year":"2005","journal-title":"Bioinformatics"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/molbev\/msl051","article-title":"Automated phylogenetic detection of recombination using a genetic algorithm.","volume":"23","author":"Kosakovsky Pond","year":"2006","journal-title":"Mol Biol Evol"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/bioinformatics\/bti320","article-title":"Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.","volume":"21","author":"Pond","year":"2005","journal-title":"Bioinformatics"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.","volume":"73","author":"Lole","year":"1999","journal-title":"J Virol"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/molbev\/msi105","article-title":"Not so different after all: a comparison of methods for detecting amino acid sites under selection.","volume":"22","author":"Kosakovsky Pond","year":"2005","journal-title":"Mol Biol Evol"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","article-title":"A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.","volume":"44","author":"Petropoulos","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.77.22.12105-12112.2003","article-title":"Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.","volume":"77","author":"Campbell","year":"2003","journal-title":"J Virol"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1128\/JVI.78.8.4234-4247.2004","article-title":"Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.","volume":"78","author":"Charpentier","year":"2004","journal-title":"J Virol"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.","volume":"6","author":"Chun","year":"2000","journal-title":"Nat Med"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/317641","article-title":"Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.","volume":"183","author":"Imamichi","year":"2001","journal-title":"J Infect Dis"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication.","volume":"105","author":"Joos","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"12344","DOI":"10.1128\/JVI.76.23.12344-12348.2002","article-title":"Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.","volume":"76","author":"Martinez-Picado","year":"2002","journal-title":"J Virol"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dki038","article-title":"The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance.","volume":"55","author":"Noe","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00126334-200404150-00005","article-title":"Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.","volume":"35","author":"Verhofstede","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-4-20210131","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/nar\/26.7.1819","article-title":"Stimulation and suppression of PCR-mediated recombination.","volume":"26","author":"Judo","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/nar\/18.7.1687","article-title":"DNA recombination during PCR.","volume":"18","author":"Meyerhans","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-0934(98)00133-5","article-title":"Minimizing DNA recombination during long RT-PCR.","volume":"76","author":"Fang","year":"1998","journal-title":"J Virol Methods"},{"key":"R40-4-20210131","first-page":"1067","article-title":"Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy.","volume":"10","author":"Brown","year":"1996","journal-title":"AIDS"},{"key":"R41-4-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.virol.2010.04.008","article-title":"Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.","volume":"404","author":"Shi","year":"2010","journal-title":"Virology"},{"key":"R42-4-20210131","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/JVI.01295-06","article-title":"Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.","volume":"81","author":"Mild","year":"2007","journal-title":"J Virol"},{"key":"R43-4-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0042-6822(03)00454-9","article-title":"Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination.","volume":"314","author":"van Rij","year":"2003","journal-title":"Virology"},{"key":"R44-4-20210131","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/viro.1995.1237","article-title":"Biological and molecular characterization of subtype D, G, and A\/D recombinant HIV-1 transmissions in Sweden.","volume":"209","author":"Leitner","year":"1995","journal-title":"Virology"},{"key":"R45-4-20210131","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1128\/JVI.68.10.6340-6346.1994","article-title":"Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.","volume":"68","author":"Sabino","year":"1994","journal-title":"J Virol"},{"key":"R46-4-20210131","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JVI.80.5.2472-2482.2006","article-title":"Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.","volume":"80","author":"Charpentier","year":"2006","journal-title":"J Virol"},{"key":"R47-4-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QAD.0b013e328331c81e","article-title":"The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.","volume":"24","author":"Buzon","year":"2010","journal-title":"AIDS"},{"key":"R48-4-20210131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.","volume":"134","author":"Martinez-Picado","year":"2008","journal-title":"Virus Res"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201106010-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:18Z","timestamp":1786042038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201106010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318215ab0a","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}